The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGattaca Regulatory News (GATC)

Share Price Information for Gattaca (GATC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 95.50
Bid: 95.00
Ask: 96.00
Change: 2.50 (2.69%)
Spread: 1.00 (1.053%)
Open: 93.00
High: 95.50
Low: 93.00
Prev. Close: 93.00
GATC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Executive Officer

19 Sep 2018 07:00

RNS Number : 1647B
Gattaca PLC
19 September 2018
 

Gattaca plc (the "Company")

 

Appointment of Chief Executive Officer

 

Gattaca plc, the specialist Engineering and Technology recruitment solutions business, is pleased to announce the appointment of Kevin Freeguard as Chief Executive Officer and member of the Board of Directors with effect from 1st October 2018.

Kevin brings a wealth of skills and experience from his most recent role at Verifone Systems Inc, where he was Managing Director of UK and Ireland from 2014 to 2018. Prior to this, he worked with De La Rue plc where he was Managing Director for their Solutions Division.

 

Patrick Shanley, Chairman, commented: "After an extensive search process, we are extremely pleased that Kevin is joining us as CEO. Kevin is an experienced international executive who has successfully led businesses across a number of sectors in his career, including Technology, Manufacturing, Financial Services and Outsourcing. He has a strong track record of business transformation, a proven ability to drive change and deliver value creation."

 

Kevin Freeguard, said: "I am delighted to be joining Gattaca at this time. The sourcing of talent is a critical and growing focus for all businesses. Gattaca's expertise in providing complete talent solutions both in the UK and internationally positions it well for the future. I am looking forward to developing the business further with the Board and the rest of the Gattaca team."

 

There are no further disclosures required to be made in respect of the appointments under Schedule 2(g) of the AIM Rules for Companies.

 

For further information please contact:

 

Gattaca plc

+44 (0) 1489 898989

Patrick Shanley, Chairman / Salar Farzad, Chief Financial Officer

Citigate Dewe Rogerson

+44 (0) 20 7638 9571

Louise Mason-Rutherford / Nick Hayns / Sam Stibbs

Numis Securities Limited

+44 (0) 20 7260 1000

Michael Meade / Kevin Cruickshank / Tom Ballard

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUWVSRWBAKAAR
Date   Source Headline
3rd May 20237:00 amRNSTransaction in Own Shares
2nd May 20237:00 amRNSTransaction in Own Shares
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20237:00 amRNSTransaction in Own Shares
24th Apr 20237:00 amRNSTransaction in Own Shares
21st Apr 20237:00 amRNSTransaction in Own Shares
20th Apr 20237:00 amRNSTransaction in Own Shares
19th Apr 20237:00 amRNSTransaction in Own Shares
17th Apr 20237:00 amRNSTransaction in Own Shares
14th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 20237:01 amRNSBlock Listing Six Monthly Return
3rd Apr 20237:00 amRNSLaunch of Share Buy-back
30th Mar 20237:00 amRNSInterim results
15th Feb 20234:40 pmRNSSecond Price Monitoring Extn
15th Feb 20234:35 pmRNSPrice Monitoring Extension
15th Feb 20237:00 amRNSTrading Statement
10th Feb 20239:05 amRNSSecond Price Monitoring Extn
10th Feb 20239:00 amRNSPrice Monitoring Extension
14th Dec 20223:02 pmRNSIssue of Ordinary Shares & Total Voting Rights
6th Dec 20221:55 pmRNSDirector/PDMR Shareholding
6th Dec 202212:55 pmRNSResult of AGM
3rd Nov 20227:00 amRNSPreliminary Results for the year ended 31 July 22
3rd Oct 202211:03 amRNSBlock Listing Six Monthly Return
29th Sep 20224:54 pmRNSEBT Share Purchase Programme
17th Aug 20227:00 amRNSTrading Update
8th Jul 202211:05 amRNSSecond Price Monitoring Extn
8th Jul 202211:00 amRNSPrice Monitoring Extension
8th Jul 20229:06 amRNSSecond Price Monitoring Extn
8th Jul 20229:00 amRNSPrice Monitoring Extension
6th May 202211:55 amRNSDirector/PDMR Shareholding
4th Apr 20224:20 pmRNSConfirmation of Director Appointment
1st Apr 20229:35 amRNSBlock listing six monthly return
31st Mar 20227:00 amRNSInterim Results
15th Mar 20227:00 amRNSBoard Succession
18th Jan 20229:05 amRNSSecond Price Monitoring Extn
18th Jan 20229:00 amRNSPrice Monitoring Extension
18th Jan 20227:00 amRNSTrading Update
16th Dec 20211:40 pmRNSDirector/PDMR Shareholding
8th Dec 20214:14 pmRNSResult of AGM
8th Dec 20214:10 pmRNSDirectorate Change
2nd Dec 202111:06 amRNSSecond Price Monitoring Extn
2nd Dec 202111:00 amRNSPrice Monitoring Extension
4th Nov 20219:05 amRNSSecond Price Monitoring Extn
4th Nov 20219:00 amRNSPrice Monitoring Extension
4th Nov 20217:00 amRNSPreliminary Results for the year ended 31 July 21
1st Oct 20219:09 amRNSBlock Listing Six Monthly Return
20th Sep 202111:00 amRNSPrice Monitoring Extension
17th Aug 20217:00 amRNSTrading Update
13th Jul 202110:50 amRNSDirector/PDMR Shareholding
17th Jun 202112:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.